AAD 2026Abstract 73603
Early and Durable Improvements in Patient-Reported Outcomes With the Targeted Oral Peptide Icotrokinra in Adolescents With Moderate-to-Severe Plaque Psoriasis
One-Year Results From the ICONIC-LEAD Study
Soung J, Lebwohl MG, Hebert A, Pink AE, Hong HCH, Iaconangelo C, Cafone J, Jiang J, Li S, Yang YW, Eichenfield L
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: PsoriasisPediatric dermatology
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.702 · Not in PubMed: details from Crossref